Membrane barrier of a porcine hepatocyte bioartificial liver

Liver Transplantation

Volumn 9, Issue 3, 2003, Pages 298-305

  Nyberg, Scott L ^a   Yagi, Toshikazu ^a   Matsushita, Takakazu ^a   Hardin, Joseph ^a   Grande, Joseph P ^a   Gibson, Lawrence E ^a   Platt, Jeffrey L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BIOARTIFICIAL ORGAN; CELL MEMBRANE; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYOPRESERVATION; DELAYED HYPERSENSITIVITY; DOG; EXPOSURE; HEMOPERFUSION; HUMORAL IMMUNITY; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER CELL; MALE; NEUTROPENIA; NONHUMAN; PERMEABILITY BARRIER; POROSITY; PRIORITY JOURNAL; SKIN TEST; SWINE; THROMBOCYTOPENIA;

EID: 0037342379     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50024     Document Type: Article

References (19)

1. Watanabe F, Mullon CJ-P, Hewitt W, Arkadopoulos N, Kahaku E, Eguchi S, et al. Clinical experience with a bioartificial liver (BAL) in the treatment of severe liver failure: A phase I clinical trial. Ann Surg 1997;225:484-494.
2. Hughes R, Nicolaou N, Langley P, Ellis A, Wendon J, Williams R. Plasma cytokine levels and coagulation and complement activation during use of the extracorporeal liver assist device in acute liver failure. Artif Organs 1998;22:854-858.
3. Te Velde A, Flendrig L, Ladiges N, Chamuleau R. Immunological consequences of the use of xenogeneic hepatocytes in a bioartificial liver for acute liver failure. Int J Artif Organs 1997;20:229-233.
4. Watts J, Douglas M, Dudley H, Gurr F, Owen J. Heterologous liver perfusions in acute liver failure. Br Med J 1967;2:341-345.
5. Chari RS, Collins BH, Magee JC, Dimaio JM, Kirk AD, Harland RC, et al. Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. N Engl J Med 1994; 331:234-236.
6. Baquerizo A, Mhoya A, Kearns-Jonker M, Arnaout W, Shackleton C, Busuttil Rt, et al. Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment. Transplantation 1999;67:5-18.
7. Nyberg S, Platt J, Shirabe K, Payne W, Hu W-S, Cerra F. Immunoprotection of xenocytes in a hollow fiber bioartificial liver. ASAIO J 1992;38:M463-M467.
8. Abouna Gm, Serrou B, Boehmig Hg, Amemiya H, Martineau G. Long-term hepatic support by intermittent multi-species liver perfusions. Lancet 1970;2:391-396.
9. Yagi T, Hardin J, Miyoshi H, Gores G, Nyberg S. Caspase inhibition reduces apoptotic death of cryopreserved porcine hepatocytes. Hepatology 2001;33:1432-1440.
10. Nyberg S, Hardin J, Matos L, Rivera D, Misra S, Gores G. Cytoprotective influence of ZVAD-fmk and glycine on gel-entrapped rat hepatocytes in a bioartificial liver. Surgery 2000;127: 447-455.
11. Shatford R, Nyberg S, Meier S, White J, Payne W, Hu W-S, et al. Hepatocyte function in a hollow fiber bioreactor: A potential bioartificial liver. J Surg Res 1992;53:549-557.
12. Platt J, Turman M, Noreen H, Fischel R, Bolman RI, Bach F. An ELISA assay for xenoreactive natural antibodies. Transplantation 1990;49:1000-1001.
13. Craddock P, Fehr J, Brigham K, Kronenberg R, Jacob H. Complement and leukocyte mediated pulmonary dysfunction in hemodialysis. N Engl J Med 1977;296:769-774.
14. Galili U, Gregory CR, Morris RE. Contribution of anti-Gal to primate and human IgG binding to porcine endothelial cells. Transplantation 1995;60:210-213.
15. Sielaff T, Nyberg S, Rollins M, Hu M, Amiot B, Lee A, et al. Characterization of the three compartment gel entrapment porcine hepatocyte bioartificial liver. Cell Biol Toxicol 1997;13:357-364.
16. Galili U, Clark M, Shohet S, Buehler J, Macher B. Evolutionary relationship between the anti-Gal antibody and the Galα1-3Gal epitope in primates. Proc Natl Acad Sci U S A 1987;84:1369-1373.
17. Galili U, Clark M, Shohet S, Macher B. Man, apes, and old world monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J Biol Chem 1988;263: 17755-17762.
18. Auchincloss H Jr. Cell-mediated xenoresponses: Strong or weak? Clin Transplant 1994;8:155-159.
19. Nyberg S, Hibbs J, Hardin J, Germer J, Persing D. Transfer of porcine endogenous retrovirus across hollow fiber membranes: Significance to a bioartificial liver. Transplantation 1999;67: 1251-1255.